Dealing with Endometriosis

Health & Lifestyle
329

Listen to article (english)

Translate to Spanish or other 102 languages!

Endometriosis can start at a person’s first menstrual period and last until menopause. Image for illustration purposes
Endometriosis can start at a person’s first menstrual period and last until menopause. Image for illustration purposes

Mega Doctor News

- Advertisement -

By Texas Tech University Health Sciences Center El Paso

Gynecology specialist Mary Ann Son, M.D. with Texas Tech Physicians of El Paso. Image Courtesy of  TTUHSC El Paso

Newswise — Endometriosis is a disease in which tissue similar to the lining of the uterus grows outside the uterus. It can cause severe pain in the pelvis, cystic growths in the ovaries and other organ spaces, and makes it harder to get pregnant.

  • Endometriosis affects roughly 10% (190 million) of reproductive age women and girls globally.
  • Endometriosis can start at a person’s first menstrual period and last until menopause.
  • It is a chronic disease associated with severe, life-impacting pain during periods, sexual intercourse, bowel movements and/or urination.
  • Access to early diagnosis and effective treatment of endometriosis is important.
  • It is important to schedule an exam with an Ob Gyn to determine if you are at risk.
- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
Innovations Making a Difference in the Fight Against Colon Cancer
Next article
Greg Manteufel’s Triumph Over a Life-Threatening Infection  

More Articles

FDA Approves First Factor Xla Inhibitor to Help Prevent Stroke in Certain Adults at High Risk 

The U.S. Food and Drug Administration today approved Sunharbo (asundexian) 50 mg tablets, the first factor XIa (FXIa) inhibitor for use in combination with antiplatelet therapy to reduce the risk of stroke in adults following a recent mild-to-moderate non-cardioembolic ischemic stroke (a stroke caused by a clot that did not originate in the heart) or a high-risk transient ischemic attack (TIA), often called a “mini-stroke.” 

Practical Health Tips to Navigate Cold and Flu Season Safely

With cold and flu season in full swing, experts say there are some simple steps you can take to protect yourself and those around you.

New Therapy for Head and Neck Squamous Cell Carcinoma Receives Accelerated FDA Approval

The U.S. Food and Drug Administration today granted accelerated approval to Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) for the treatment of adults with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) whose disease has progressed on or after platinum-based chemotherapy and immunotherapy.

DHR Health to Host 13th Annual Circle of Care Caregivers Conference

DHR Health Rehabilitation Hospital will host its 13th Annual Circle of Care Caregivers Conference on Saturday, November 7, 2026, at the Edinburg Conference Center at Renaissance, offering educational presentations and resources for individuals caring for family members and loved ones.
- Advertisement -